Cited by 3,627Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Whitehouse, PJ, Price, DL, Struble, RG, Clark, AW, Coyle, JT, DeLong, Mahlon R.·1982·Science

DOI 10.1126/science.7058341

Open this paper in CoChat — free account

Abstract

Recent evidence indicates that the nucleus basalis of Meynert, a distinct population of basal forebrain neurons, is a major source of cholinergic innervation of the cerebral cortex. Postmortem studies have previously demonstrated profound reduction in the presynaptic markers for cholinergic neurons in the cortex of patients with Alzheimer's disease and senile dementia of the Alzheimer's type. The results of this study show that neurons of the nucleus basalis of Meynert undergo a profound (greater than 75 percent) and selective degeneration in these patients and provide a pathological substrate of the cholinergic deficiency in their brains. Demonstration of selective degeneration of such neurons represents the first documentation of a loss of a transmitter-specific neuronal population in a major disorder of higher cortical function and, as such, points to a critical subcortical lesion in Alzheimer's patients.

Integrity signals

Registry

Crossref · 10.1126/science.7058341

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Self-citation
APRIORITY
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat
Krettek, J. E., & Price, J. L. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901780204 · Cited by 1,293
The connections of the septal region in the rat
Swanson, L. W., & Cowan, W. M. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901860408 · Cited by 1,136
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
Shute, C. C. D., & Lewis, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,120
HIPPOCAMPAL PROJECTIONS AND RELATED NEURAL PATHWAYS TO THE MID-BRAIN IN THE CAT
Nauta, W. J. H. (1958) · Brain · doi:10.1093/brain/81.3.319 · Cited by 990
Some morphometric aspects of the brain in senile dementia of the alzheimer type
Terry, R. D., Peck, A., DeTeresa, R., Schechter, R., & Horoupian, D. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100209 · Cited by 801
Activity of pallidal neurons during movement.
DeLong, M. R. (1971) · Journal of Neurophysiology · doi:10.1152/jn.1971.34.3.414 · Cited by 734
Self-citation
Neurotransmitter enzyme abnormalities in senile dementia
Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724

Flagged first, then by citations

Show all 44 references

Research works printed but not linked: 10

Brody, H., Alzheimer's Disease: Senile Dementia and Related Disorders 7: 345 (1978).
Coyle, J. T., Brain Neurotransmitters and Receptors in Aging and Age-Related Disorders: 149 (1981).
DAVIS, K.L., BRAIN ACETYLCHOLINE: 205 (1979).
DRACHMAN, D.A., AGING 7: 141 (1978).
HASSLER, R, BEHAV AGING NERVOUS: 284 (1965).
KUHAR, M.J., BIOL CHOLINERGIC FUN: 3 (1976).
PARENT, A, ADVANCES IN NEUROLOGY 24: 1 (1979).
TOMLINSON, B.E., DEMENTIA: 113 (1977).
WANG, H, AGING DEMENTIA: 1 (1977).
WANG, H.S., REPORT PANEL INFLAMM: 61 (1979).

Sorted by citations

Items 601–700 of 1,021

Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα
Mockett, B. G., Richter, M., Abraham, W. C., & Müller, U. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00030 · Cited by 127
Hippocampal cholinergic neurostimulating peptides (HCNP)
Ojika, K., Mitake, S., Tohdoh, N., Appel, S. H., Otsuka, Y., Katada, E., & Matsukawa, N. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00021-0 · Cited by 115
Estrogen Induces Estrogen Receptor α-Dependent cAMP Response Element-Binding Protein Phosphorylation via Mitogen Activated Protein Kinase Pathway in Basal Forebrain Cholinergic NeuronsIn Vivo
Szegő, É. M., Barabás, K., Balog, J., Szilágyi, N., Korach, K. S., Juhász, G. D., & Ábrahám, I. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0222-06.2006 · Cited by 117
Alzheimer’s Disease and the Aging Brain
Terry, R. D. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291079 · Cited by 118
Psychosis of Alzheimer’s disease is associated with elevated muscarinic M 2 binding in the cortex
Lai, M. K. P., Lai, O. –., Keene, J., Esiri, M. M., Francis, P. T., Hope, T., & Chen, C. (2001) · Neurology · doi:10.1212/wnl.57.5.805 · Cited by 114
Altered structural proteins in plaques and tangles: What do they tell us about the biology of Alzheimer's disease?
Selkoe, D. J. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90055-2 · Cited by 116
Long‐term modifications in intrinsic neuronal properties and rule learning in rats
Saar, D., & Barkai, E. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02699.x · Cited by 114
Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
Kumar, U., & Patel, S. C. (2007) · Brain Research · doi:10.1016/j.brainres.2006.10.049 · Cited by 112
Mapping muscarinic receptors in human and baboon brain using [N‐11C‐methyl]‐benztropine
Dewey, S. L., MacGregor, R. R., Brodie, J. D., Bendriem, B., King, P. T., Volkow, N. D., Schlyer, D. J., Fowler, J. S., Wolf, A. P., Gatley, S. J., et al. (1990) · Synapse · doi:10.1002/syn.890050307 · Cited by 114
Chapter 25 Modulation of brain aging correlates by long-term alterations of adrenal steroids and neurally-active peptides
Landfield, P. W. (1987) · Progress in brain research · doi:10.1016/s0079-6123(08)60215-0 · Cited by 112
ALCOHOLIC DEMENTIA: A HYPOTHESIS
Lishman, W. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91162-1 · Cited by 113
Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
Eriksen, J. L., & Janus, C. G. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9118-z · Cited by 146
Recommended Measures for the Assessment of Cognitive and Physical Performance in Older Patients with Dementia: A Systematic Review
Bossers, W. J. R., van der Woude, L. H. V., Boersma, F., Scherder, E., & van Heuvelen, M. J. G. (2012) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000345038 · Cited by 113
Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology
Lippa, C. F., Smith, T. W., & Perry, E. K. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050176 · Cited by 114
Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease
Tan, M. G., Chua, W. T., Esiri, M. M., Smith, A. D., Vinters, H. V., & Lai, M. K. P. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22290 · Cited by 116
Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinus
Bons, N., Mestre‐Francés, N., & Petter, A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90016-q · Cited by 113
Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's‐type dementia
Chan‐Palay, V., Lang, W., Haesler, U., Köhler, C., & Yasargil, G. M. (1986) · The Journal of Comparative Neurology · doi:10.1002/cne.902480307 · Cited by 112
Highly selective effects of nerve growth factor, brain‐derived neurotrophic factor, and neurotrophin‐3 on intact and injured basal forebrain magnocellular neurons
Koliatsos, V. E., Price, D. L., Gouras, G. K., Cayouette, M. H., Burton, L. E., & Winslow, J. W. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903430206 · Cited by 114
Self-citation
Dementia and motor neuron disease: Morphometric, biochemical, and Golgi studies
Horoupian, D. S., Thal, L. J., Katzman, R., Terry, R. D., Davies, P., Hirano, A., DeTeresa, R. M., Fuld, P. A., Petito, C. K., Blass, J. P., et al. (1984) · Annals of Neurology · doi:10.1002/ana.410160306 · Cited by 113
Selective Delayed Response Deficits in Parkinson's and Alzheimer's Disease
Freedman, M., & Oscar‐Berman, M. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520090026011 · Cited by 113
Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis
Kotani, S., Yamauchi, T., Teramoto, T., & Ogura, H. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.04.004 · Cited by 112
Altered synaptic function in Alzheimer's disease
Bell, K. F. S., & Cuello, A. C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.045 · Cited by 117
Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits
Ariano, M. A., Larson, E. R., Noblett, K. L., Sibley, D. R., & Levine, M. S. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199708)26:4 · Cited by 57
The behavioral functions of the cholinergic basalforebrain : lessons from 192 IgG‐SAPORIN
Wrenn, C. C., & Wiley, R. G. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00071-9 · Cited by 112
Dendritic changes in the basal nucleus of meynert and in the diagonal band nucleus in Alzheimer's disease—A quantitative Golgi investigation
Arendt, T., Zveuintshva, H. G., & Lkontovich, T. A. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90141-7 · Cited by 112
Aging is associated with a diffuse impairment of forebrain cholinergic neurons
Altavista, M. C., Rossi, P., Bentivoglio, A. R., Crociani, P., & Albanese, A. (1990) · Brain Research · doi:10.1016/0006-8993(90)91116-x · Cited by 112
Stability of numbers but not size of mouse forebrain cholinergic neurons to 53 months
Hornberger, J. C., Buell, S. J., Flood, D. G., McNeill, T. H., & Coleman, P. D. (1985) · Neurobiology of Aging · doi:10.1016/0197-4580(85)90003-x · Cited by 112
Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert
Aigner, T. G., Mitchell, S. J., Aggleton, J. P., DeLong, M. R., Struble, R. G., Price, D. L., Wenk, G. L., & Mishkin, M. (1987) · Psychopharmacology · doi:10.1007/bf00210833 · Cited by 112
Self-citation
Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer’s disease
Lai, M. K. P., Tsang, S. W., Alder, J. T., Keene, J., Hope, T., Esiri, M. M., Francis, P. T., & Chen, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2077-2 · Cited by 110
Tacrine alters the secretion of the beta‐amyloid precursor protein in cell lines
Lahiri, D. K., Lewis, S., & Farlow, M. R. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370612 · Cited by 112
Evidence for a role of the neuropeptide galanin in spatial learning
Ögren, S. O., Hökfelt, T. G. M., Kask, K., et al. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90463-c · Cited by 111
A Fluorescence “Turn-On” Ensemble for Acetylcholinesterase Activity Assay and Inhibitor Screening
Peng, L., Zhang, G., Zhang, D., Xiang, J., Zhao, R., Wang, Y., & Zhu, D. (2009) · Organic Letters · doi:10.1021/ol9016723 · Cited by 110
Presenile dementia combined with amyotrophy: a review of 34 Japanese cases
Morita, K., Kaiya, H., Ikeda, T., & Namba, M. (1987) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(87)90026-4 · Cited by 110
Reevaluation of the contribution of the basal forebrain cholinergic system to memory
Kesner, R. P. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80122-2 · Cited by 111
Galantamine for Alzheimer's disease
Prvulovic, D., Hampel, H. J., & Pantel, J. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003592137 · Cited by 113
Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease
Tuszynski, M. H., & Blesch, A. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)46028-7 · Cited by 108
On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease
Capsoni, S., & Cattaneo, A. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9112-2 · Cited by 110
Reversible inactivation of the nucleus basalis magnocellularis induces disruption of cortical acetylcholine release and acquisition, but not retrieval, of aversive memories
Miranda, M. I., & Bermúdez‐Rattoni, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6478 · Cited by 109
Effects of amyloid-β-(25–35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat
Yamaguchi, Y., & Kawashima, S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00730-0 · Cited by 109
Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels
Isaacson, L. G., Saffran, B. N., & Crutcher, K. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90062-5 · Cited by 109
Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?
Ferreira, M. E. S., de Vasconcelos, A. S., Vilhena, T. D. C., da Silva, T. L., Barbosa, A. D. S., Gomes, A. R. Q., Dolabela, M. F., & Percário, S. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0157-y · Cited by 112
The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
Cuello, A. C., Pentz, R., & Hall, H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00062 · Cited by 112
When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration
Michalska, P., & Leon, R. M. (2020) · Antioxidants · doi:10.3390/antiox9080740 · Cited by 119
Pharmacologic modelling of Alzheimer's disease
Sunderland, T., Tariot, P. N., Weingartner, H., Murphy, D. L., NEWHOUSE, P. A., Mueller, E. A., & Cohen, R. M. (1986) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(86)90030-8 · Cited by 108
Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats
Vannucchi, M. G., Scali, C., Kopf, S. R., Pepeu, G., & Casamenti, F. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00091-2 · Cited by 108
Region- and peptide-specific regulation of the neurotrophins by estrogen
Jezierski, M., & Sohrabji, F. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00244-8 · Cited by 108
N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease
Toiber, D., Berson, A., Greenberg, D., Melamed‐Book, N., Diamant, S., & Soreq, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003108 · Cited by 107
Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells
Stolzing, A., & Grune, T. (2004) · The FASEB Journal · doi:10.1096/fj.03-0374fje · Cited by 107
Integrated phylogeny of the primate brain, with special reference to humans and their diseases
Rapoport, S. I. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90004-8 · Cited by 108
Neurochemical aspects on aging and diseases with cognitive impairment
Gottfries, C. G. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270415 · Cited by 110
Interaction of Alzheimer's Presenilin-1 and Presenilin-2 with Bcl-XL
Passer, B. J., Pellegrini, L., Vito, P., Ganjei, J. K., & D'adamio, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24007 · Cited by 107
Galanin immunoreactivity is increased in the nucleus basalis of meynert in Alzheimer's disease
Beal, M. F., MacGarvey, U. M., & Swartz, K. J. (1990) · Annals of Neurology · doi:10.1002/ana.410280207 · Cited by 107
Nerve growth factor binding in aged rat central nervous system: Effect of acetyl‐l‐carnitine
Angelucci, L., Ramacci, M. T., Taglialatela, G., et al. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490200413 · Cited by 107
Basal Forebrain Cholinergic Neurons and Alzheimer’s Disease
Höhmann, C. F., Antuono, P., & Coyle, J. T. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8_2 · Cited by 106
Self-citation
Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment
Paul, S., Jeon, W. K., Bizon, J. L., & Han, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00043 · Cited by 106
Neurofibrillary degeneration and neuronal loss in alzheimer's disease
Bondareff, W., Mountjoy, C. Q., Roth, M., & Hauser, D. L. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90007-9 · Cited by 109
Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat
Koliatsos, V. E., Applegate, M. D., Knüsel, B., Junard, E. O., Burton, L. E., Mobley, W. C., Hefti, F. F., & Price, D. L. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90066-l · Cited by 106
Self-citation
Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105
Senile plaques: staining for acetylcholinesterase and A4 protein: a comparative study in the hippocampus and entorhinal cortex
ULRICH, J., Meier‐Ruge, W., Probst, A., Meier, E., & Ipsen, S. (1990) · Acta Neuropathologica · doi:10.1007/bf00307630 · Cited by 105
The unsolved relationship of brain aging and late-onset Alzheimer disease
Kern, A., & Behl, C. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.016 · Cited by 108
MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.
Hanyu, H., Asano, T., Sakurai, H., Tanaka, Y., Takasaki, M., & Abe, K. (2002) · PubMed Central · Cited by 105
Allosteric Modulation of Nicotinic Receptors as a Treatment Strategy for Alzheimer’s Disease
Maelicke, A. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051227 · Cited by 106
Nongeniculate afferents to striate cortex in macaques
Doty, R. W. (1983) · The Journal of Comparative Neurology · doi:10.1002/cne.902180204 · Cited by 105
Nerve growth factor receptors in the central nervous system
Springer, J. E. (1988) · Experimental Neurology · doi:10.1016/0014-4886(88)90231-2 · Cited by 104
ProNGF Induces PTEN via p75 NTR to Suppress Trk-Mediated Survival Signaling in Brain Neurons
Song, W., Volosin, M., Cragnolini, A. B., Hempstead, B. L., & Friedman, W. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2581-10.2010 · Cited by 104
Donepezil in the treatment of patients with Alzheimer’s disease
Tsuno, N. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.23 · Cited by 104
Neurochemical basis for symptomatic treatment of Alzheimer's disease
Francis, P. T., Ramírez, M. J., & Lai, M. K. P. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.010 · Cited by 104
Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease
Rasool, C. G., Svendsen, C. N., & Selkoe, D. J. (1986) · Annals of Neurology · doi:10.1002/ana.410200407 · Cited by 105
Cells containing immunoreactive estrogen receptor-α in the human basal forebrain
Donahue, J. E., Stopa, E. G., Chorsky, R. L., King, J. C., Schipper, H. M., Tobet, S. A., Blaustein, J. D., & Reichlin, S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02413-0 · Cited by 103
Cholinergic innervation of mouse forebrain structures
Kitt, C. A., Höhmann, C. F., COYLE, J. T., & Price, D. L. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903410110 · Cited by 104
Self-citation
Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis.
Deacon, E. M., Pongracz, J. E., Griffiths, G., & Lord, J. M. (1997) · Molecular Pathology · doi:10.1136/mp.50.3.124 · Cited by 104
Neuronal Pentraxin 1 Contributes to the Neuronal Damage Evoked by Amyloid-β and Is Overexpressed in Dystrophic Neurites in Alzheimer's Brain
Abad, M. A., Enguita, M., DeGregorio-Rocasolano, N., Ferrer, I., & Trullas, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0575-06.2006 · Cited by 102
Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease
Drolle, E., Negoda, A. E., Hammond, K., Pavlov, E. V., & Leonenko, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182194 · Cited by 106
Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2
Hanisch, U., Seto, D., & Quirion, R. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03368.1993 · Cited by 103
Cholinergic deficit in Alzheimer's disease: A study based on CSF and autopsy data
Reinikainen, K. J., Riekkinen, P. J., Palj�rvi, L., et al. (1988) · Neurochemical Research · doi:10.1007/bf00973325 · Cited by 103
Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease
Beal, M. F., Mazurek, M. F., Svendsen, C. N., Bird, E. D., & Martin, J. B. (1986) · Annals of Neurology · doi:10.1002/ana.410200408 · Cited by 105
Effects of anabaseine‐related analogs on rat brain nicotinic receptor binding and on avoidance behaviors
Meyer, E. M., de Fiebre, C. M., Hunter, B. E., Simpkins, C. E., Frauworth, N., & de Fiebre, N. E. C. (1994) · Drug Development Research · doi:10.1002/ddr.430310207 · Cited by 103
Acetylcholine-rich neuronal grafts in the forebrain of rats: Effects of environmental enrichment, neonatal noradrenaline depletion, host transplantation site and regional source of embryonic donor cells on graft size and acetylcholinesterase-positive fibre outgrowth
Dunnett, S. B., Whishaw, I. Q., Bunch, S., & Fine, A. (1986) · Brain Research · doi:10.1016/0006-8993(86)90939-x · Cited by 103
Treatment strategies for senile dementia: antagonist β-carbolines
Sarter, M. F., Schneider, H. H., & Stephens, D. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90042-2 · Cited by 103
Improvement of cognitive function and physical activity of aging mice by human neural stem cells over-expressing choline acetyltransferase
Park, D., Yang, Y., Bae, D. K., Lee, S. H., Yang, G., Kyung, J., Kim, D., Choi, E., Lee, S. W., Kim, G., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.026 · Cited by 102
Acetylcholinesterase inhibitive activity-guided isolation of two new alkaloids from seeds of Peganum nigellastrum Bunge by an in vitro TLC- bioautographic assay
Zheng, X.-Y., Zhang, Z., Chou, G., et al. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1910-x · Cited by 102
Ontogeny of cholinergic neurons in the mouse forebrain
Schambra, U. B., Sulik, K. K., Petrusz, P., & Lauder, J. M. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902880109 · Cited by 102
Choline-Induced Spatial Memory Facilitation Correlates with Altered Distribution and Morphology of Septal Neurons
Loy, R., Heyer, D., Williams, C. L., et al. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-0145-6_21 · Cited by 102
Parkinson's disease and Alzheimer's disease: hypersensitivity to X rays in cultured cell lines.
Robbins, J. H., Otsuka, F., Tarone, R. E., Polinsky, R. J., Brumback, R. A., & Nee, L. E. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.9.916 · Cited by 100
Cholinergic receptors in human brain: Effects of aging and alzheimer disease
Giacobini, E. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270416 · Cited by 102
Cholinergic imaging in dementia spectrum disorders
Roy, R., Niccolini, F., Pagano, G., & Politis, M. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3349-x · Cited by 101
Redox active metals in neurodegenerative diseases
Acevedo, K. M., Masaldan, S., Opazo, C., & Bush, A. I. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01731-9 · Cited by 102
Cholinergic neuropathology in a mouse model of Alzheimer's disease
German, D. C., Yazdani, U., Speciale, S. G., Pasbakhsh, P., Games, D., & Liang, C. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10737 · Cited by 101
Cholinergic drug effects and brain muscarinic receptor binding in aged rats
Pedigo, N. W., Minor, L. D., & Krumrei, T. N. (1984) · Neurobiology of Aging · doi:10.1016/0197-4580(84)90067-8 · Cited by 101
Aged Non‐Human Primates: An Animal Model of Age‐Associated Neurodegenerative Disease
Price, D. L., Martin, L. J., Sisodia, S. S., Wagster, M. V., Koo, E. H., Walker, L. C., Koliatsos, V. E., & Cork, L. C. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00672.x · Cited by 100
Self-citation
Combined administration of D-galactose and aluminium induces Alzheimerlike lesions in brain
Xiao, F., Xiao-guang, L., Zhang, X., Hou, J.-D., Lin, L.-F., Gao, Q. F., & Luo, H. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1028-2 · Cited by 100
New Insights on the Role of Manganese in Alzheimer’s Disease and Parkinson’s Disease
Martins, A. C., Morcillo, P., Ijomone, O. M., Venkataramani, V., Harrison, F. E., Lee, E.-S., Bowman, A. B., & Aschner, M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16193546 · Cited by 101
Intrinsic vesicular glutamate transporter 2‐immunoreactive input to septohippocampal parvalbumin‐containing neurons: Novel glutamatergic local circuit cells
Hajszán, T., Alreja, M., & Léránth, C. (2004) · Hippocampus · doi:10.1002/hipo.10195 · Cited by 99
Selective 5-HT1A Antagonists WAY 100635 and NAD-299 Attenuate the Impairment of Passive Avoidance Caused by Scopolamine in the Rat
Misane, I., & Ögren, S. O. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300024 · Cited by 100
Neurotransmitter and Receptor Deficits in Senile Dementia of the Alzheimer Type
Quirion, R., Martel, J.-C., Robitaille, Y., Etienne, P. E., Wood, P. L., Nair, N. P. V., & Gauthier, S. G. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037215 · Cited by 100
Multiple-Dose Arecoline Infusions in Alzheimer's Disease
Tariot, P. N. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800340023003 · Cited by 100
Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease
Young, L. T., Kish, S. J., Li, P. P., & Warsh, J. J. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90295-9 · Cited by 100
Noradrenergic changes and memory loss in aged mice
Leslie, F. M., Loughlin, S. E., Sternberg, D. B., McGaugh, J. L., Young, L. E., & Zornetzer, S. F. (1985) · Brain Research · doi:10.1016/0006-8993(85)91439-8 · Cited by 100
From eyes‐closed to eyes‐open: Role of cholinergic projections in EC‐to‐EO alpha reactivity revealed by combining EEG and MRI
Wan, L., Huang, H., Schwab, N., Tanner, J., Rajan, A., Lam, N. B., Zaborszky, L., Li, C. R., Price, C. C., & Ding, M. (2019) · Human Brain Mapping · doi:10.1002/hbm.24395 · Cited by 96
An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
Iulita, M. F., Ower, A., Barone, C., Pentz, R., Gubert, P., Romano, C., Cantarella, R. A., Elia, F., Buono, S., Recupero, M., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.05.001 · Cited by 99

Authors: Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R.
Affiliations: Johns Hopkins University (US)
Neuropathology Laboratory, Departments of Pathology and Neurology, Baltimore, Maryland 21205
Departments of Pharmacology and Experimental Therapy, Psychiatry, and Neuroscience, Baltimore, Maryland 21205
ORCID: DeLong, Mahlon R.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1982-03-05
Volume: 215
Issue: 4537
Pages: 1237-1239
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.7058341
OpenAlex: W2093374391
Semantic Scholar: e0380e88fdffd5a546eb76a1d2eb7d05db143f94
Cited by: 3,627
References: 44
Citations by year: 2026: 52 · 2025: 42 · 2024: 53 · 2023: 67 · 2022: 62 · 2021: 91 · 2020: 95 · 2019: 66 · 2018: 63 · 2017: 66 · 2016: 82 · 2015: 65 · 2014: 73 · 2013: 63 · 2012: 56
FWCI: 110.00
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: Alzheimer's disease, senile dementia, nucleus basalis of Meynert, basal forebrain, cholinergic neurons, neuronal loss, cholinergic deficit, cerebral cortex, presynaptic markers, subcortical lesions
MeSH terms: Acetylcholine, Alzheimer Disease, Basal Ganglia, Dementia, Humans, Neural Pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks